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Abstract
Background: Recently in a number of studies, it has been demonstrated that the innate immune
system doesn't merely acts as the first line of defense but provides critical signals for the
development of specific adaptive immune response. Innate immune system employs a set of
receptors called pattern recognition receptors (PRRs) that recognize evolutionarily conserved
patterns from pathogens called pathogen associated molecular patterns (PAMPs). In order to assist
scientific community, a database PRRDB has been developed that provides extensive information
about pattern recognition receptors and their ligands.
Results: The current version of database contains around 500 patterns recognizing receptors from
77 distinct organisms ranging from insects to human. This includes 177 Toll-like receptors, 124 are
Scavenger receptors and 67 are Nucleotide Binding Site-Leucine repeats rich receptors. The
database also provides information about 266 ligands that includes carbohydrates, proteins, nucleic
acids, glycolipids, glycoproteins, lipopeptides. A number of web tools have been integrated in
PRRDB in order to provide following services: i) searching on any field; ii) database browsing; and
iii) BLAST search against the pattern-recognition receptors. PRRDB also provides external links to
standard databases like Swiss-Prot and Pubmed.
Conclusion: PRRDB is a unique database of its kind, which provides comprehensive information
about innate immunity. This database will be very useful in designing effective adjuvant for subunit
vaccine and in understanding role of innate immunity. The database is available from the URL's in
the Availabiltiy and requirements section.
Background
More than 20 million premature deaths occur every year
in the world due to infectious diseases. Every year billions
of dollars are spent for the treatment of patients suffering
from such diseases, which in turn, poses a great economic
burden on the developing nations. Thus, protection of
mankind from these dreaded diseases is one of the major
challenges in the present era. Fortunately, we have effec-
tive vaccines against a number of diseases (e.g. smallpox,
polio), which not only save millions of lives but also
endows long lasting immunity against these diseases. But
these vaccines are available only against a few diseases and
the vaccines against the other infectious diseases like
malaria, tuberculosis are still wanted. So, developing
effective and cheap vaccines against all the infectious dis-
eases is the need of the hour. Strategies to develop vac-
cines have changed tremendously over the time i.e. from
whole pathogen to antigens and from antigens to anti-
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gens and antigenic regions are called subunit vaccines.
They are safer and have more advantage than the vaccines
based on whole organisms. Tremendous efforts have been
made in the field of subunit vaccines. However, only very
limited success has been achieved so far, as epitopes/anti-
gens alone fail to elicit a robust and sustained immune
response, thereby defeating the main goal of vaccination
i.e. to provide strong and long lasting immunity. There-
fore, in order to elicit an optimal immune response
against a pathogen, there is a need to stimulate innate and
adaptive immune response simultaneously [1-4]. Innate
immune system has ability to recognize the pathogens
using evolutionarily conserved patterns of pathogens
called pathogen associated molecular patterns or PAMPs
[5,6]. This natural potential of innate immune system has
successfully been exploited and it is observed that addi-
tion of such microbial components to experimental vac-
cines leads to development of robust and durable
adaptive immune response. It has now been realized that
purified and synthetic components of microbial extracts
or PAMPs exert potent adjuvant effects [7-9]. Thus both
antigen/epitope and adjuvant are equally important for
vaccine design.
Most of the effects of the above mentioned PAMPs now
appear to be mediated by receptors belonging to a class of
innate immunity receptors called pattern recognition
receptors or PRRs. Pattern-recognition receptors (PRRs)
including non-phagocytic receptors, such as Toll-like
receptors, Nucleotide Oligomerization Domain (NOD)
proteins and receptors that induce phagocytosis, such as
Scavenger receptors, mannose receptors and β-glucan
receptors. PRRs when stimulated by PAMPs lead to activa-
tion of adaptive antigen-recognition receptors subse-
quently inducing the expression of key co-stimulatory
molecules and cytokines [2] as well as maturation and
migration of other cells. Expression of co-stimulatory
molecule on the surface of antigen presenting cells is
absolutely necessary to flag the antigen presented by the
same antigen presenting cells, as being of microbial origin
and activation of antigen specific T cells. In tandem, this
creates an inflammatory environment that leads to the
establishment of the adaptive immune response [3,4]. So,
understanding the molecular mechanism responsible for
the recognition of PAMPs and generation of downstream
signaling would be crucial for the development of new
approaches to vaccine formulation and immunotherapy.
In this study, an attempt has been made to collect and
compile the information from literature related to innate
immunity for the first time. We mainly collected pattern
recognition receptors (PRRs) of innate immunity and evo-
lutionary conserved patterns of pathogens recognized by
innate immunity called pathogen associated molecular
patterns (PAMPs). Though the information about the
PRRs may be fetched from other source like Swiss-Prot
etc., the information about the more important PAMPs
are scattered in the literature. So we have exerted to collect
the information about PAMPs or other PRR ligands and
tried to make them available from a single source. The
detailed information about the PAMPs include the name
of the PAMP (PRR ligand), receptor it binds to, its source,
its origin and the most important, the chemical structure
of the ligand (a textual description is provided in case the
structure is not available). The ligands collected include
the natural ligands as well as their modified derivatives
like LPS (natural lipopolysaccharide) and MPL (modified
derivative of LPS). This information in form of a database
will be very useful for understanding the innate immune
system and developing tools for predicting effective adju-
vants. To the best of author's knowledge, no such database
exists till date.
Database Description
PostgresSQL relational database management system
(RDBMS) has been used for storing, retrieving and man-
aging the data. All the scripts have been written using pro-
gramming language PERL. CGIperl is used for common
gateway interface and Pgperl for accessing information
from PostgreSQL. The server PRRDB has been developed
and launched on SUN machine T1000 under Solaris 10.0
environment using Apache server. The aim of PRRDB
database is to provide; i) comprehensive information
about the PRRs and their ligands, ii) tools for extraction
and analysis of this information and, iii) hyperlinks to
related databases. The overall architecture of PRRDB is
shown in Figure 1. The database consists of two tables
name PRRs and ligands. The detailed description of both
the tables is as follows:
PRRs Table
This table provides comprehensive information about the
pattern recognition receptors. It contains around 500 PRR
sequences belonging to 77 distinct organisms, ranging
from insects to humans. Out of these 177 are Toll-like
receptors, 124 are Scavenger receptors, 20 are mannose
receptors, 41 are C-type lectin like domain containing
receptors, 17 are DC-SIGN receptors, 43 are Peptidogly-
can recognition receptors and 67 are Nucleotide binding
site-Leucine rich repeats rich receptors. Information about
the PRRs includes their common names, synonymous
names, organisms they belong to, sequence length and
protein sequence. These receptors are further classified as
single-pass type I/II membrane proteins, multi-pass mem-
brane proteins, cytoplasmic or secreted proteins depend-
ing upon their site of expression. Each entry also bears a
Swiss-Prot ID that is hyperlinked to its corresponding
entry in Swiss-Prot. In this database we kept only wellPage 2 of 6
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ment or protein from cDNA libraries.
Ligand Table
This table provides information about 266 ligands of
PRRs. It provides complete information about ligands
that include ligands name, source, binding receptor and
its origin i.e. exogenous/endogenous. A total of 86 ligands
out of 266 are endogenous in origin whereas the rest
belong to the exogenous sources. The exogenous ligands
may be bacterial, mycobacterial, fungal, viral, environ-
mental or synthetic in nature. PRRDB cover a wide range
of ligands, which are further classified into carbohydrates,
proteins, nucleic acids, glycolipids, glycoproteins,
lipopeptides, lipopolysaccharides, lipoteichoic acids, pep-
tidoglycans, phospholipids, synthetic and others (ligands
which could not be assigned to any group). A reference
field is also added to the database where links are main-
tained to the relevant literature (Pubmed).
Web tools
PRRDB also provides a number of online tools that allow
users to retrieve and analyze the information. These web
tools have been designed to facilitate the user in retrieving
information from the database.
Keyword search for PRRs
Keyword search option allow users to perform a search on
all fields of the database. A user can also perform a specific
and precise query just by entering a keyword and selecting
the field in which the keyword shall be looked for. The
result generated in response to a query carries along with
A schematic representation of database PRRDBFigur  1
A schematic representation of database PRRDB. This figure gives a detailed architecture of database PRRDB. On the 
bottom side of the figure, tables of the database and fields of respective table are listed. On the top of the figure are the names 
of pattern-recognition receptors for which information is present in PRRDB. The left side provides a listing of the various types 
of PAMPs included in the database and the right side gives various web tools available for searching and browsing the database.Page 3 of 6
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which is hyperlinked to its corresponding Swiss-Prot
information page (Figure 2). If a user wishes to get the
sequence of the receptor sequence in fasta format, he can
click the hyperlink provided.
Keyword search for ligands
This option works just as stated above, but for the ligands
(Figure 3). The names of the ligands are hyperlinked to an
html page displaying the chemical structure of the ligand
(Figure 4) if it is available otherwise a brief description
about ligand is provided. The reference field is also
present where links are maintained to the relevant litera-
ture (mainly Pubmed) whenever that is readily present.
Browse PRRs
PRRDB provides browsing PRRs facility where users may
browse a group or set of receptors. For example user may
display all Toll-like receptors stored in PDRB by a single
click. One of the major advantages of browsing over key-
word search is that users may examine receptors even if
they do not know appropriate keyword.
Browse Ligands
Similar to "Browse PRRs", PRRDB also provides facility
for browsing ligands where user may browse different
type of ligands. Browsing of ligands includes browsing of
following type of ligands carbohydrates, proteins, Nucleic
acids, peptides, lipoproteins etc.
BLAST search
One of the powerful features of PRRDB is similarity
search. Users may search their protein sequence against
known PRRs in PRRDB for similarity search using BLAST
[10]. This allows user to annotate their query protein. If
the query protein has high similarity with any receptor
sequence in PRRDB than user may annotate his protein.
This is very useful features for checking whether a given
sequence is a PRR.
Potential utility and limitations
In the past few years research in the field of subunit vac-
cine designing has been focused mainly on searching for
potential candidates or epitopes that could be used as
antigens. For this reason a large number of bioinformatics
databases [11-17] and tools [18-23] have been developed
for predicting antigenic epitopes or antigens. Recent stud-
ies clearly indicate that it is not the antigens alone but a
combination of antigen and adjuvant that is required to
optimally elicit an immune response. There is a need to
activate adaptive as well as innate immune system. This
database would help the bioinformaticians and immu-
nologists to understand the interaction between PRRs and
PAMPs. Apart from the comprehensive information about
the PRRs that may be available elsewhere this database
also houses information about the PRR ligands collected
from the published literature. Collection of PAMPs at one
single place has never been done before. The database
Output of keyword search on receptorsFigure 2
Output of keyword search on receptors. Typical display of output result for keyword search performed on receptors. 
Here a search for TLR 10 was performed and all fields were selected for display.
Output of PRRDB database for keyword search on ligandsFigure 3
Output of PRRDB database for keyword search on 
ligands. An example of output result for keyword search on 
ligands performed in PRRDB. A search was performed for 
getting the information about the ligand CL075.Page 4 of 6
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structures of the ligands (or textual description in case
structure is not available). As these PAMPs belong to a
wide range of organisms, the representative structure is
given e.g. if TLR4 binds to lipid A that may be present in
any of the gram-negative bacteria, then the structure of E.
coli lipid A is given. This would help the scientists to look
into the fine structural details that are required for a PAMP
to act as an adjuvant. One of the main problems for using
PAMPs as adjuvants is the toxic effect exhibited by most of
them. Therefore, the ligands collected include the infor-
mation about a parent PAMP that shows toxic effect when
used as adjuvant as well as its modified derivatives that is
much safer to use. For example, it is known that LPS binds
to TLR4 and can act as an adjuvant but it is toxic and pyro-
genic. Whereas, its modified derivative MPL is non-pyro-
genic and retains the TLR4 activating property. Examples
like these would help the scientists to look into the struc-
tural details and study what is the minimal region
required for the desired activity and is safer at the same
time. Briefly, the information available at PRRDB will be
very useful for immunologist to understand immune sys-
tem and in designing novel and improved subunit vac-
cines. Major limitation of this database is that it has
limited information, not suitable for deriving the general-
ized rules. We hope, over the time information on innate
immunity will increase and so would grow the size of the
database. This is the first attempt towards understanding
pathogen/ligands recognition mechanism of innate
immune system and for rational ligands/adjuvants
designing.
Availability and requirements
PRRDB is available at: http://www.imtech.res.in/raghava/
prrdb/
or: http://bioinformatics.uams.edu/ragahva/prrdb/
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The chemical structure of ligand CL075 as displayed in PRRDBFigure 4
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